2026 schedule status · updated 28 October 2026

Which childhood vaccine schedule applies in the US in 2026?

US childhood vaccine recommendations changed several times in 2026: a revised CDC schedule, a court stay and two executive orders. This page states what is in effect, for whom, and what is still pending, with each body's own wording and a source for every entry. It does not recommend for or against any vaccine.

Short answer (as of 28 October 2026)

Get an email when this page changes (Open Source Medicine Foundation newsletter; next scheduled check 8 November 2026)

What is pending

What applies, by question

What CDC recommendsCDC 2025 schedule (July 2025 addendum). COVID-19 vaccination is shared clinical decision-making for healthy children 6 months to 17 years (May 2025 directive). Other vaccines are as in the 2025 schedule.
Private insurance (ACA)Most non-grandfathered plans must cover, without cost-sharing, vaccines with an ACIP recommendation in effect that CDC has adopted; with the January 2026 schedule and the 2025 ACIP votes stayed, the earlier recommendations are the ones in effect. Insurers in AHIP have also pledged no-cost coverage of ACIP-recommended vaccines through the end of 2027; self-insured employer plans may not be bound by that pledge.
Vaccines for Children (VFC)VFC follows ACIP's VFC resolutions. The Congressional Research Service found the January 2026 schedule did not appear to change which vaccines VFC covers. EO 14407 states that vaccines in every schedule category should remain covered by VFC without cost-sharing.
School and child-care entrySet by each state under state law and rules. EO 14420 sec. 2(d) only advises states to consider updating their laws; it does not change them. See your state's page for its current requirements.
State recommendationsMany states recommend the American Academy of Pediatrics (AAP) schedule. KFF counted 28 jurisdictions (27 states and DC) as of 20 January 2026, including the West Coast Health Alliance and the Northeast Public Health Collaborative. No later full count was found.

State rules: school vaccine requirements by state · official exemption forms.

Side by side, by vaccine

The shaded column is the schedule in effect. The other columns are shown for comparison and use each body's own category names.

VaccineCDC (posted, 2025 schedule): in effectCDC January 2026 (stayed by court)AAP 2026EO 14420 tier (sec. 2(a))
Measles, mumps, rubellaRoutineAll childrenRoutineAll children; sec. 2(b): "three separate single-disease shots once such products are domestically available"
Diphtheria, tetanus, pertussisRoutineAll childrenRoutineAll children
PolioRoutineAll childrenRoutineAll children
HibRoutineAll childrenRoutineAll children
PneumococcalRoutineAll childrenRoutineAll children
VaricellaRoutineAll childrenRoutineAll children
HPVRoutine at 11–12 (from 9); 2 doses if started at 9–14All children; 1 dose (per CRS)RoutineAll children
Hepatitis BRoutine, birth dose within 24 hours for stable infants ≥2,000 gHigh-risk (mother HBsAg-positive or unknown); shared decision otherwiseRoutine, universal birth doseListed in both high-risk and shared decision-making
Hepatitis ARoutine, 2 doses at 12–23 monthsHigh-risk and shared decisionRoutineListed in both high-risk and shared decision-making
RotavirusRoutineShared decisionRoutineShared decision-making
InfluenzaRoutine, annual from 6 monthsShared decisionRoutine, annual from 6 monthsShared decision-making
COVID-19Shared decision for healthy children 6 months–17 years (May 2025 directive, not stayed)Shared decisionRecommended at 6–23 months and for high-risk children; available to othersShared decision-making
RSV monoclonal antibodyNirsevimab for infants whose mothers were not vaccinated; second season for high-riskHigh-risk groupsDepends on maternal vaccination; high-risk in second seasonHigh-risk
Meningococcal ACWYRoutine at 11–12 with booster at 16High-risk and shared decisionRoutine at 11–12High-risk; "meningococcal disease" also in shared decision-making
Meningococcal BShared decision at 16–23; high-risk per notesHigh-riskHigh-risk and shared decisionHigh-risk; also shared decision-making
DengueHigh-risk onlyHigh-riskHigh-riskHigh-risk

AAP 2026 age and dose details come partly from secondary summaries of the AAP schedule (26 January 2026). In EO 14420, hepatitis A, hepatitis B and meningococcal vaccines appear in more than one tier and the order does not say which children fall in each. The January 2026 column is shown for reference only; it is not in effect.

Timeline

Each entry is dated and sourced; "secondary source only" marks entries not confirmed from a court, agency or Federal Register document.

  1. 2025-05-27 · HHS · Primary source

    HHS Secretary directive on COVID-19 vaccine for healthy children and pregnant women (background)

    Secretary Kennedy ordered CDC to stop recommending COVID-19 vaccination for pregnant women and 'healthy' children. CDC implemented it by removing the pregnancy recommendation and moving the child recommendation from routine to shared clinical decision-making (SCDM), without an ACIP vote (as described in the 16 Mar 2026 court order).

    Effect on what applies: NOT stayed by the 16 Mar 2026 order (the court found plaintiffs had not shown a justiciable claim against it). COVID-19 for healthy children 6 mo-17 y therefore remains SCDM on the currently posted CDC schedule.

    Sources: Memorandum and Order on Plaintiffs' Motion for Preliminary Injunction, AAP v. Kennedy, No. 1:25-cv-11916-BEM, ECF 291 (pp. 6-7, 22-25) (U.S. District Court, D. Mass. (copy hosted by Civil Rights Litigation Clearinghouse)) · Child and Adolescent Immunization Schedule Notes (COVID-19 section) (CDC)

  2. 2025-06-09 · HHS · Primary source

    All 17 ACIP members removed; new members appointed from 11 Jun 2025 (background)

    HHS Secretary removed all 17 sitting ACIP members and appointed new ones (appointments dated 11 Jun 2025, 11 Sep 2025 and 13 Jan 2026 per the court order).

    Effect on what applies: The 13 appointments made on those dates were stayed on 16 Mar 2026; ACIP has not met in 2026.

    Sources: Changes to CDC Vaccine Recommendations in 2025 and 2026 (CRS Insight IN12684) (Congressional Research Service) · AAP v. Kennedy, ECF 291 (Conclusion, p. 45) (U.S. District Court, D. Mass.)

  3. 2025-06-25 to 2025-12-05 · ACIP / CDC · Primary source

    Reconstituted ACIP votes: June 2025 (thimerosal-free flu vaccines; clesrovimab), September 2025 (COVID-19 to SCDM; MMRV not recommended under age 4), December 2025 (hepatitis B birth dose to individual-based decision-making for infants of HBsAg-negative mothers) (background)

    The court order describes three challenged votes: June 2025 thimerosal vote, September 2025 COVID-19 routine-to-SCDM vote, and December 2025 vote '8 to 3 to recommend individual-based decision-making' for the hepatitis B vaccine, including the birth dose, for infants born to women who test negative. CDC adopted these into its schedules (e.g., CDC release of 6 Oct 2025 on COVID-19 and standalone chickenpox vaccination for toddlers).

    Effect on what applies: The 16 Mar 2026 order 'STAYS all votes taken by the now-stayed ACIP'. CRS reports the status of clesrovimab (June 2025 vote, not on the January 2025 schedule) is 'unclear'. The currently posted CDC notes again show a routine hepatitis B birth dose and permit MMRV.

    Sources: AAP v. Kennedy, ECF 291 (pp. 9, 44-45) (U.S. District Court, D. Mass.) · Changes to CDC Vaccine Recommendations in 2025 and 2026 (CRS Insight IN12684) (Congressional Research Service)

  4. 2025-08-14 · HHS · Primary source

    HHS reinstates the Task Force on Safer Childhood Vaccines (background)

    Statutory task force under the National Childhood Vaccine Injury Act of 1986 (42 U.S.C. 300aa-27), disbanded in 1998, reinstated by the Secretary.

    Effect on what applies: None directly. This is the body EO 14420 later tasks with a 90-day plan.

    Sources: Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making (Background, sec. I.B) (HHS / Federal Register)

  5. 2025-12-05 · White House · Primary source

    Presidential Memorandum: 'Aligning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries'

    Directed HHS/CDC to review peer-country childhood schedules and, if those practices are judged superior, update the U.S. core schedule while preserving access. Cited the U.S. recommending vaccines against 18 diseases for all children vs 10 in Denmark, 14 in Japan, 15 in Germany (per search excerpts of the memo; full text not read directly).

    Effect on what applies: None by itself; it is the stated basis for the 5 Jan 2026 CDC memo and for EO 14407 and EO 14420.

    Sources: Aligning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries (The White House) · EO 14420, sec. 1 (cites the memorandum by name and date) (Federal Register)

  6. 2026-01-05 · CDC / HHS · Primary source

    CDC revises the childhood immunization schedule (Acting CDC Director decision memo)

    Acting CDC Director Jim O'Neill (HHS Deputy Secretary) signed a decision memo accepting an HHS scientific assessment of peer-country schedules. CDC kept three categories ('Immunizations Recommended for All Children', '...for Certain High-Risk Groups or Populations', '...Based on Shared Clinical Decision-Making'), each stated to require insurance coverage without cost-sharing. Recommended for all children: measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Hib, pneumococcal, HPV, varicella (routine immunizations reduced from 17 to 11). Per the court order: RSV, hepatitis A, hepatitis B, MenACWY, MenB and dengue limited to high-risk groups; rotavirus, COVID-19, influenza, hepatitis A, hepatitis B and meningococcal moved to SCDM. Per CRS R48982: HPV changed to one dose. Denmark: the memo states the Director relied on discussions with health officials from Japan, Germany and Denmark; the CDC release cites Denmark ('immunizes children against 10 diseases') as the low end of the comparison. Official documents describe alignment with 'peer, developed countries' (20 countries per CRS), not a copy of Denmark's schedule; 'modelled on Denmark' is media framing (the 10 'consensus' diseases do coincide with Denmark's 10, plus varicella).

    Effect on what applies: Took effect on the CDC website in January 2026; stayed on 16 Mar 2026 and no longer in effect. The government's appeal does not challenge the stay of this memo.

    Sources: CDC Acts on Presidential Memorandum to Update Childhood Immunization Schedule (CDC) · AAP v. Kennedy, ECF 291 (pp. 10-11, describing the January 2026 Memo) (U.S. District Court, D. Mass.) · The 2026 Childhood Immunization Schedule (CRS Report R48982) (Congressional Research Service) · US childhood vaccine schedule: Denmark differences (requester-supplied; returned HTTP 403, not read) (Axios)

  7. 2026-01-05 / 2026-01-12 · States (West Coast Health Alliance; Northeast Public Health Collaborative) · Primary source

    State alliances say they will keep recommending the AAP schedule

    West Coast Health Alliance (California, Hawaii, Oregon, Washington) continued to endorse the AAP schedule (Oregon Health Authority statement, 5 Jan 2026, cited by CRS). Northeast Public Health Collaborative, 12 Jan 2026: 'continues to recommend the American Academy of Pediatrics' (AAP)' schedule; it describes itself as a voluntary coalition and 'does not necessarily speak on behalf of every member agency or state'.

    Effect on what applies: State-level recommendations only; they do not change federal coverage rules. School-entry requirements remain set by each state's law and rules.

    Sources: Northeast Public Health Collaborative Recommends American Academy of Pediatrics Vaccine Schedule (New Jersey Department of Health) · The 2026 Childhood Immunization Schedule (CRS R48982), n. 127 (Congressional Research Service)

  8. 2026-01-22 · States (as tallied by KFF) · Secondary source only

    KFF count: 28 jurisdictions (27 states + DC) not following some or all of the January 2026 CDC recommendations

    As of 20 Jan 2026: 25 jurisdictions (incl. DC) decoupled for all childhood vaccines, most pointing to AAP; Alaska and Mississippi (hepatitis B only) and Arizona (hepatitis B and COVID-19) partially. KFF identifies no state that explicitly adopted the January 2026 CDC schedule.

    Effect on what applies: State recommendations; predates the court stay. Not updated for later events.

    Sources: State Recommendations for Routine Childhood Vaccines: Increasing Departure from Federal Guidelines (KFF)

  9. 2026-01-26 · AAP · Primary source

    AAP publishes its 2026 childhood and adolescent immunization schedule

    AAP 'continues to recommend routine immunization for protection against 18 diseases' (RSV, hepatitis A and B, rotavirus, influenza, COVID-19, MMR, diphtheria, tetanus, pertussis, polio, Hib, varicella, meningococcal, pneumococcal, HPV). Released in AAP Red Book Online; endorsed by other medical organizations (secondary reports say 12, incl. AMA, AAFP, ACOG, IDSA). CRS cites a 5 Feb 2026 date (likely the Pediatrics journal publication).

    Effect on what applies: Professional-society guidance. Used as the reference schedule by many states. It does not by itself set federal insurance, VFC or school requirements.

    Sources: AAP's recommended childhood and adolescent immunization schedule for 2026 (AAP (HealthyChildren.org)) · AAP publishes 2026 childhood and adolescent immunization schedule (Contemporary Pediatrics)

  10. 2026-02-24 · States (state attorneys general) / court · Primary source

    Multistate lawsuit Arizona v. Kennedy filed (N.D. Cal., No. 3:26-cv-01609)

    Plaintiff states (led by Arizona) challenge the 5 Jan 2026 CDC decision memo, arguing Congress designated ACIP, not CDC alone, to set the schedules that trigger federal obligations.

    Effect on what applies: No relief granted as of the latest information found; the AAP case stay is what blocks the January schedule.

    Sources: Unlawful Overhaul of the Childhood Immunization Schedule (Arizona v. Kennedy, N.D. Cal.) (Oregon Department of Justice) · Attorney General Mayes Leads Multistate Lawsuit Challenging the Kennedy Vaccine Schedule (Arizona Attorney General)

  11. 2026-03-16 · Court (U.S. District Court, D. Mass.) · Primary source

    District court stays the January 2026 schedule, 13 ACIP appointments and all votes of the reconstituted ACIP (AAP v. Kennedy, D. Mass. No. 1:25-cv-11916-BEM, ECF 291, Judge Brian E. Murphy)

    Ordering paragraphs: '(i) The Court STAYS the January 2026 Memo revising the CDC's childhood immunization schedule pursuant to 5 U.S.C. § 705. (ii) The Court STAYS the appointments of the thirteen ACIP members appointed on June 11, 2025, September 11, 2025, and January 13, 2026. (iii) The Court further STAYS all votes taken by the now-stayed ACIP.' The court held the memo was likely contrary to law (Director acted without ACIP) and arbitrary and capricious. It declined to enjoin ACIP from meeting and declined relief on the May 2025 COVID-19 directive. Reported at 823 F. Supp. 3d 141.

    Effect on what applies: CRS: the changes 'presently have no effect and the agency cannot implement them'; schedules 'largely reverted' to the January 2025 versions, except the April 2025 ACIP recommendations and the May 2025 COVID-19 change remain in effect. (Georgetown CCF described this as the June 2024-adopted schedule being back in effect; CRS R48982 also mentions 'May 2025' in one place. The order itself does not name a replacement schedule.) The claim 'reverted to January 2025 schedule' is accurate only with those two exceptions.

    Sources: Memorandum and Order on Plaintiffs' Motion for Preliminary Injunction, ECF 291 (U.S. District Court, D. Mass.) · Changes to CDC Vaccine Recommendations in 2025 and 2026 (CRS IN12684) (Congressional Research Service) · Court Order Presses Pause on New ACIP Committee and Changes to Childhood Vaccination Schedule (Georgetown CCF)

  12. 2026-03-18 / 2026-06-24 / 2026-10-21 · CDC (ACIP) · Primary source

    All three scheduled 2026 ACIP meetings cancelled (18-19 Mar, 24-26 Jun, 21-23 Oct)

    CDC ACIP meetings page lists each: 'Due to ongoing litigation, this meeting is cancelled'.

    Effect on what applies: No new ACIP recommendations in 2026, including none for 2026-27 influenza or COVID-19 vaccines. CDC's July 2025 influenza recommendations carry forward (Immunize.org).

    Sources: ACIP Meetings (CDC) · Ask the Experts: Influenza vaccine recommendations (Immunize.org)

  13. 2026-04 / 2026-05-19 · HHS / CDC · Secondary source only

    Revised ACIP charter renewed

    Charter renewed (effective 1 Apr 2026 per secondary sources; CRS cites Federal Register notices of 6 Apr and 19 May 2026). Broadens eligible expertise, adds focus on vaccine safety, removes a fixed meeting schedule, and 'directs the committee to consider other preventive measures'.

    Effect on what applies: No members have been newly appointed under it as far as found; ACIP has not met.

    Sources: Changes to CDC Vaccine Recommendations in 2025 and 2026 (CRS IN12684) (Congressional Research Service) · New ACIP Charter Signals Possible Change in Priorities for Committee (Georgetown CCF)

  14. 2026-04-29 · Court / DOJ · Primary source

    Federal government appeals the 16 Mar order to the First Circuit (No. 26-1503)

    Notice of Appeal (ECF 306, filed 04/29/26) appeals 'this Court's March 16, 2026, Memorandum and Order on Plaintiffs' Motion for Preliminary Injunction, ECF No. 291.' (The government's brief says the notice was filed 15 April; the docketed notice is dated 29 April.) Separately, proposed intervenors appealed denial of intervention on 25 Mar 2026 (No. 26-1325).

    Effect on what applies: An appeal does not suspend the stay; no stay pending appeal was reported granted.

    Sources: Defendants' Notice of Appeal, ECF 306 (U.S. District Court, D. Mass. (copy hosted by Georgetown Litigation Tracker)) · AAP v. Kennedy case page (Civil Rights Litigation Clearinghouse)

  15. 2026-05 (late May) · Insurers (AHIP) · Secondary source only

    AHIP members commit to no-cost-sharing coverage of ACIP-recommended immunizations through end of 2027

    Per CRS: AHIP said members would cover 'all ACIP-recommended immunizations with no cost-sharing through the end of 2027', including those recommended via SCDM; extends a September 2025 commitment for 2026. Blue Cross Blue Shield companies made a similar pledge in April 2026 (Immunize.org). Voluntary; CRS notes self-insured employer plans may not be bound.

    Effect on what applies: Voluntary commitment on top of the legal requirement (PHSA §2713) tied to recommendations 'in effect' from ACIP.

    Sources: The 2026 Childhood Immunization Schedule (CRS R48982) (Congressional Research Service) · IZ Express issue 1877: AHIP member insurance plans commit to continue first-dollar vaccine coverage through 2027 (Immunize.org)

  16. 2026-05-29 · White House · Primary source

    Executive Order 14407, 'Realigning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries' (91 FR 33575, 3 Jun 2026, FR Doc. 2026-11180)

    Acknowledges the HHS scientific assessment as a 'guiding resource'; directs CDC and ACIP to review it and, to the extent permitted by law, update the child and adolescent schedule, considering 'maximum flexibility' on timing and sequencing; directs agencies to align actions, regulations, funding and coverage with the ACIP-/CDC-adopted schedule, and states immunizations in any schedule category should continue to be covered without cost sharing by private insurance, Medicaid, CHIP and VFC; directs HHS to inform state officials and make the assessment available for review of state vaccination laws. No deadlines.

    Effect on what applies: Did not itself change the schedule; routes changes through ACIP/CDC, which remain blocked by the stay.

    Sources: Executive Order 14407 (Federal Register Vol. 91, No. 106) (Federal Register / GovInfo) · Fact Sheet: President Donald J. Trump Realigns U.S. Core Childhood Vaccine Recommendations... (The White House)

  17. 2026-06-12 to 2026-06-18 · Court / DOJ · Primary source

    Government seeks expedited appeal; files opening brief limited to the ACIP (FACA) relief

    Government brief (No. 26-1503, dated filed 06/18/2026): 'This appeal challenges the FACA-based structural relief only. It does not seek to disturb the stay of the January 5 Memo, which rests on independent grounds, and it does not ask this Court to disturb the stay of the CDC-adopted ACIP votes in the interim.' A motion to expedite was announced 12 Jun 2026 (Philadelphia Inquirer).

    Effect on what applies: Even if the government wins this appeal, the stay of the January 2026 schedule and of the 2025 ACIP votes is not at issue in it.

    Sources: Brief for Federal Defendants-Appellants, No. 26-1503 (1st Cir.) (U.S. Court of Appeals for the First Circuit (copy hosted by Courthouse News)) · Kennedy asks appeals court to expedite vaccine schedule appeal (Philadelphia Inquirer)

  18. 2026-07-23 / 2026-09-11 · Court (D. Mass.) · Secondary source only

    District court pauses AAP v. Kennedy proceedings pending the appeal

    23 Jul 2026: renewed motion to stay proceedings granted until 3 Sep 2026 (Clearinghouse). 11 Sep 2026: proceedings paused until the First Circuit rules (Medical Daily, citing STAT).

    Effect on what applies: Pauses merits litigation only; the 16 Mar stay remains in place.

    Sources: AAP v. Kennedy case page (Civil Rights Litigation Clearinghouse) · Judge Pauses Pediatricians' Lawsuit Over Kennedy's Vaccine Changes as Families Await October 6 Appeals Court Argument (Medical Daily)

  19. 2026-08-10 · White House · Primary source

    Executive Order 14420, 'Delivering Gold Standard Childhood Vaccine Recommendations for Americans' (91 FR 53173, 14 Aug 2026, FR Doc. 2026-16730)

    Sec. 1 notes implementation of prior directives 'has been delayed due to litigation over the composition of the Advisory Committee on Immunization Practices and separate updates to the Federal vaccine schedule.' Sec. 2(a) declares 'Gold Standard Childhood Vaccine Recommendations' in three categories: (i) recommended for all children: measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Hib, pneumococcal disease, HPV, varicella; (ii) certain high-risk groups or populations: RSV monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, dengue; (iii) shared clinical decision-making: hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, COVID-19. Sec. 2(b): MMR 'should be administered in three separate single-disease shots once such products are domestically available' and, 'to the maximum extent feasible, all childhood immunizations should be administered at separate medical visits.' Sec. 2(c): agencies to advance them 'to the fullest extent allowable by law.' Sec. 2(d): states 'are advised to review' and 'consider updating' school-requirement laws. Sec. 3: HHS, through the Task Force on Safer Childhood Vaccines, to present plans 'within 90 days' on single-antigen options starting with MMR (while 'guaranteeing continued availability of combination vaccines'), timing/sequencing, alternative adjuvants to aluminum, risk/benefit evaluation, and safety monitoring. Sec. 4: Attorney General to support 'meritorious legal actions' against state laws, including on religious and medical exemptions; DOJ, Education and HHS to ensure contractors and grantees, including states, comply with obligations including exemptions 'to the extent applicable under Federal law'.

    Effect on what applies: Policy declaration; it does not amend the CDC schedule, which remains subject to the court stay. The tier lists match the stayed January 2026 categories. Sec. 5(c): creates no enforceable rights. 90-day plan deadline falls on 8 Nov 2026.

    Sources: Executive Order 14420 (Federal Register Vol. 91, No. 156, pp. 53173-53175) (Federal Register / GovInfo) · eo-14420.pdf (requester-supplied; same GPO-signed FR text) (The White House) · Trump orders childhood vaccine overhaul: 6 things to know (requester-supplied; returned HTTP 403, not read) (Becker's Hospital Review)

  20. 2026-08-24 · HHS (Office of the Secretary / ASPE) · Primary source

    HHS Request for Information on federal vaccine recommendation categories and shared clinical decision-making (Docket HHS-OS-2026-0332; 91 FR 54724)

    Issued 'in support of the Task Force on Safer Childhood Vaccines and in furtherance of' EO 14420. Seeks comment on whether the routine, risk-based and SCDM categories 'are adequate' and 'whether additional or different categories should be adopted', including 'a presumption in favor of individual autonomy and religious freedom' and 'the downstream legal and programmatic consequences of category assignment'. Comments due 20 Sep 2026. (A 26 Aug 2026 joint letter asked for an extension to 23 Oct 2026; outcome not found.)

    Effect on what applies: None yet; information-gathering step.

    Sources: Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making (Federal Register / HHS)

  21. 2026-08-24 / 2026-10-08 · State (Florida Department of Health) · Primary source

    Florida proposes removing hepatitis B, varicella, Hib and pneumococcal conjugate vaccines from school and child-care entry requirements (Rule 64D-3.046)

    Public hearing held 8 Oct 2026. Polio, diphtheria, measles, rubella, pertussis, mumps and tetanus requirements in s. 1003.22, Florida Statutes, 'remain in place'. The hearing 'does not constitute final adoption of the rule.' (WUSF reported the proposal 24 Aug 2026.)

    Effect on what applies: Not final as of the latest source; current Florida school requirements unchanged until adoption and effective date.

    Sources: Florida Department of Health Holds Public Hearing on Proposed Revisions to School Immunization Rule (Florida Department of Health) · Florida seeks to repeal four vaccines from school entry requirements (WUSF)

  22. 2026-09-01 · CDC (as reported by Immunize.org) · Secondary source only

    CDC 2026-27 influenza interim clinical considerations; July 2025 flu recommendations carried forward

    Immunize.org: 'CDC's influenza vaccination recommendations from the July 2025 CDC immunization schedules remain in effect for 2026-27' under the court orders; CDC 'continues to recommend annual influenza vaccination for all people without a contraindication' from 6 months. Immunize.org gives both 1 Sep and 2 Sep 2026 for the clinical considerations. AAP issued its own 2026-27 influenza policy statement.

    Effect on what applies: Routine annual flu vaccination from 6 months remains the federal recommendation (not SCDM).

    Sources: Ask the Experts: Influenza vaccine recommendations (Immunize.org) · Recommendations for Prevention and Control of Influenza in Children, 2026-2027: Policy Statement (AAP / Pediatrics)

  23. 2026-09-08 · Court (U.S. District Court, N.D. Cal.) · Secondary source only

    Arizona v. Kennedy: motion to dismiss granted in part, denied in part (Judge Vince Chhabria)

    Per Courthouse News: states may proceed with claims against the CDC's removal of universal-recommendation status from childhood vaccines; claims about the replacement of ACIP members dismissed. The Oregon DOJ tracker confirms the date and disposition only.

    Effect on what applies: No change; case continues.

    Sources: Arizona v. Kennedy tracker entry (Oregon Department of Justice) · Judge trims lawsuit challenging RFK's new childhood vaccine schedule (Courthouse News Service)

  24. 2026-10-06 · Court (U.S. Court of Appeals, First Circuit) · Secondary source only

    First Circuit hears oral argument in AAP v. Kennedy, No. 26-1503

    Reported issues: scope of the remedy (stay of all 13 appointments), plaintiffs' standing, and whether the court has appellate jurisdiction. No decision reported as of 28 Oct 2026.

    Effect on what applies: None yet. Stay remains in effect.

    Sources: Who's Calling the Shots? Vaccine Policy in Court (Groom Law Group) · Appeals panel wrestles with block of RFK Jr.'s vaccine panel appointments (not read; HTTP 403) (The Hill)

  25. 2026-10-28 · CDC · Primary source

    Status check: CDC website still posts the 2025 child and adolescent schedule

    CDC schedule pages list 'Recommendations for Ages 18 Years or Younger, United States, 2025' (addendum updated 2 Jul 2025). Notes show: COVID-19 SCDM for healthy children 6 mo-17 y; annual influenza for all from 6 mo; hepatitis B birth dose within 24 h for medically stable infants >=2,000 g; nirsevimab (clesrovimab not listed); routine hepatitis A, rotavirus, MenACWY; MenB SCDM 16-23 y; HPV 2 doses if started 9-14; MMRV permitted. No notice about the court order appears on the pages.

    Effect on what applies: This is the federal CDC schedule currently presented as in effect.

    Sources: Child and Adolescent Immunization Schedule by Age (CDC) · Child and Adolescent Immunization Schedule Notes (CDC)

  26. 2026-11-08 · HHS · Primary source

    PENDING: 90-day deadline for HHS Task Force plans under EO 14420 sec. 3

    90 days from 10 Aug 2026 is Sunday 8 Nov 2026. No plan found published as of 28 Oct 2026.

    Effect on what applies: Plans go to the President; they would not by themselves change the CDC schedule while the stay is in place.

    Sources: Executive Order 14420, sec. 3 (Federal Register)

Common questions

Is the new 2026 childhood vaccine schedule in effect?

No. As of 28 October 2026 the January 2026 CDC schedule is stayed by a federal court order of 16 March 2026 (AAP v. Kennedy). CDC posts and applies its 2025 schedule, with COVID-19 vaccination as shared clinical decision-making for healthy children.

What does Executive Order 14420 change?

EO 14420 (10 August 2026) directs agencies to organise childhood vaccine recommendations into three tiers (all children, high-risk groups, shared clinical decision-making), says MMR should be offered as three single-disease shots once such products are available in the US, and asks HHS for plans within 90 days (8 November 2026). It does not itself change the CDC schedule now posted.

What is shared clinical decision-making?

A CDC recommendation category in which vaccination is decided individually between a patient or parent and a clinician, rather than recommended for everyone in an age group. Vaccines in this category remain covered by most insurance and by VFC.

Do school vaccine requirements change?

Not because of the federal actions alone. School and child-care requirements are set by each state; check your state's page for its current rules and exemptions.

Compare with other countries: US vs Denmark and 33 other countries.

Researched from court filings, the Federal Register, CDC, the Congressional Research Service and AAP; status as of 28 October 2026. Not medical or legal advice. Corrections: corrections page.